Neurology
Journal
-
- Overview
-
- Identity
-
- View All
-
Overview
publication venue for
-
Association of Changes in C-Reactive Protein Level Trajectories Through Early Adulthood With Cognitive Function at Midlife: The CARDIA Study..
103:-.
2024
-
Long-Term Depressive Symptom Trajectories and Midlife Cognition: The CARDIA Study..
103:-.
2024
-
Predicting Driving Cessation Among Cognitively Normal Older Drivers: The Role of Alzheimer Disease Biomarkers and Clinical Assessments..
102:-.
2024
-
Investigating White Matter Neuroinflammation in Alzheimer Disease Using Diffusion-Based Neuroinflammation Imaging..
102:-.
2024
-
Associations of Polycystic Ovary Syndrome With Indicators of Brain Health at Midlife in the CARDIA Cohort..
102:-.
2024
-
Screening for Cognitive Decline in Isolated/Idiopathic REM Sleep Behavior Disorder: Which Test Is Best?.
102:-.
2024
-
Validation of the RBD Symptom Severity Scale in the North American Prodromal Synucleinopathy Consortium..
102:-.
2024
-
Association Between Sleep Quantity and Quality in Early Adulthood With Cognitive Function in Midlife..
102:-.
2024
-
Association of Poor Oral Health With Neuroimaging Markers of White Matter Injury in Middle-Aged Participants in the UK Biobank..
102:-.
2023
-
Association Between Triglycerides and Risk of Dementia in Community-Dwelling Older Adults: A Prospective Cohort Study..
101:e2288-e2299.
2023
-
Associations Between Traumatic Brain Injury and Cognitive Decline Among Older Male Veterans: A Twin Study..
101:e1761-e1770.
2023
-
Clinical Reasoning: A 48-Year-Old Man With Spasticity and Progressive Ataxia..
101:e1747-e1752.
2023
-
Association of Plasma Biomarkers of Alzheimer Disease With Cognition and Medical Comorbidities in a Biracial Cohort..
101:e1402-e1411.
2023
-
Retrospective Evaluation of Neuropathologic Proxies of the Minimal Atrophy Subtype Compared With Corticolimbic Alzheimer Disease Subtypes..
101:e1412-e1423.
2023
-
Polygenic Susceptibility to Hypertension and Cognitive Performance in Middle-aged Persons Without Stroke or Dementia..
101:e512-e521.
2023
-
Clinicoradiologic and Neuropathologic Evaluation of Corticobasal Syndrome..
101:e289-e299.
2023
-
Longitudinal Relationships of White Matter Hyperintensities and Alzheimer Disease Biomarkers Across the Adult Life Span..
101:e164-e177.
2023
-
Associations of Enlarged Perivascular Spaces With Brain Lesions, Brain Age, and Clinical Outcomes in Chronic Traumatic Brain Injury..
101:e63-e73.
2023
-
Genetic Moderation of the Association of β-Amyloid With Cognition and MRI Brain Structure in Alzheimer Disease..
101:e20-e29.
2023
-
Association of Mitochondrial DNA Copy Number With Brain MRI Markers and Cognitive Function: A Meta-analysis of Community-Based Cohorts..
100:e1930-e1943.
2023
-
Evaluating the Association Between Genetically Proxied Neurodevelopmental Language Phenotypes and the Risk of Primary Progressive Aphasia..
100:e1922-e1929.
2023
-
Blood Biomarkers in Neurodegenerative Diseases: Implications for the Clinical Neurologist..
101:172-180.
2023
-
Premature Cardiovascular Disease and Brain Health in Midlife: The CARDIA Study..
100:e1454-e1463.
2023
-
Polygenic Susceptibility to Hypertension and Blood Pressure Control in Stroke Survivors..
100:e1587-e1597.
2023
-
Interim Safety Profile From the Feasibility Study of the BrainGate Neural Interface System..
100:e1177-e1192.
2023
-
Cognitive and Functional Trajectories in Older Adults With Prediagnostic Parkinson Disease..
100:e1386-e1394.
2022
-
Association of Choroid Plexus Inflammation on MRI With Clinical Disability Progression Over 5 Years in Patients With Multiple Sclerosis..
100:e911-e920.
2022
-
Combined Effects of Synaptic and Axonal Integrity on Longitudinal Gray Matter Atrophy in Cognitively Unimpaired Adults..
99:e2285-93.
2022
-
Association of Obesity With Cognitive Decline in Black and White Americans..
100:e220-e231.
2022
-
Estimating Bidirectional Transitions and Identifying Predictors of Mild Cognitive Impairment..
100:e297-e307.
2022
-
Association of CSF GAP-43 With the Rate of Cognitive Decline and Progression to Dementia in Amyloid-Positive Individuals..
100:e275-e285.
2022
-
Opinion and Special Article: The Need for Specialized Training in Women's Neurology..
100:38-42.
2022
-
Socioeconomic Status, Biological Aging, and Memory in a Diverse National Sample of Older US Men and Women..
99:e2114-e2124.
2022
-
Association of β-Amyloid and Vascular Risk on Longitudinal Patterns of Brain Atrophy..
99:e270-80.
2022
-
Investigating Heterogeneity and Neuroanatomic Correlates of Longitudinal Clinical Decline in Atypical Alzheimer Disease..
98:e2436-45.
2022
-
Plasma P-tau181 and P-tau217 in Patients With Traumatic Encephalopathy Syndrome With and Without Evidence of Alzheimer Disease Pathology..
99:e594-e604.
2022
-
Predicting Amyloid Positivity in Cognitively Unimpaired Older Adults: A Machine Learning Approach Using A4 Data..
98:e2425-e2435.
2022
-
Effect of Race on Prediction of Brain Amyloidosis by Plasma Aβ42/Aβ40, Phosphorylated Tau, and Neurofilament Light..
99:e245-e257.
2022
-
Prediction of Naming Outcome With FMRI Language Lateralization in Left Temporal Epilepsy Surgery..
98:e2337-e2346.
2022
-
Progression to Dementia or Reversion to Normal Cognition in Mild Cognitive Impairment as a Function of Late-Onset Neuropsychiatric Symptoms..
98:e2132-e2139.
2022
-
Association of Emerging β-Amyloid and Tau Pathology With Early Cognitive Changes in Clinically Normal Older Adults..
98:e1512-e1524.
2022
-
Clinicopathologic Factors Associated With Reversion to Normal Cognition in Patients With Mild Cognitive Impairment..
98:e2036-e2045.
2022
-
Associations of Lower Extremity Peripheral Nerve Impairment and Risk of Dementia in Black and White Older Adults..
98:e1837-e1845.
2022
-
Cerebral Microbleeds, Cerebral Amyloid Angiopathy, and Their Relationships to Quantitative Markers of Neurodegeneration..
98:e1605-e1616.
2022
-
Associations of Stages of Objective Memory Impairment With Amyloid PET and Structural MRI: The A4 Study..
98:e1327-e1336.
2022
-
Cognitive Outcome 1 Year After Mild Traumatic Brain Injury: Results From the TRACK-TBI Study..
98:e1248-e1261.
2022
-
Association of Loneliness With 10-Year Dementia Risk and Early Markers of Vulnerability for Neurocognitive Decline..
98:e1337-e1348.
2022
-
Twenty-Five-Year Change in Cardiac Structure and Function and Midlife Cognition: The CARDIA Study..
98:e1040-e1049.
2022
-
Adherence to Antiseizure vs Other Medications Among US Medicare Beneficiaries With and Without Epilepsy..
98:e427-36.
2022
-
Teaching NeuroImage: Neurovascular Consequences of Autonomic Dysreflexia..
98:e441-e442.
2022
-
Association of Cognitive Impairment With Free Water in the Nucleus Basalis of Meynert and Locus Coeruleus to Transentorhinal Cortex Tract..
98:e700-e710.
2021
-
Simulation-Based Assessment of Graduate Neurology Trainees' Performance Managing Acute Ischemic Stroke..
97:e2414-e2422.
2021
-
Cerebral Amyloid Angiopathy Pathology and Its Association With Amyloid-β PET Signal..
97:e1799-e1808.
2021
-
Predicting Symptom Onset in Sporadic Alzheimer Disease With Amyloid PET..
97:e1823-e1834.
2021
-
Association of Age With Contrast-Enhancing Lesions Across the Multiple Sclerosis Disease Spectrum..
97:e1334-e1342.
2021
-
Aducanumab, Amyloid Lowering, and Slowing of Alzheimer Disease..
97:543-544.
2021
-
Comparing PET and MRI Biomarkers Predicting Cognitive Decline in Preclinical Alzheimer Disease..
96:e2933-43.
2021
-
Experience of Community Neurologists Providing Care for Patients With Neurodegenerative Illness During the COVID-19 Pandemic..
97:e988-e995.
2021
-
Clinical, Imaging, and Pathologic Characteristics of Patients With Right vs Left Hemisphere-Predominant Logopenic Progressive Aphasia..
97:e523-e534.
2021
-
Progressive Neurologic Symptoms in the Setting of HIV: A Rare Case of Neurosymptomatic CSF HIV Escape..
97:389-390.
2021
-
Association of Aortic Stiffness With Biomarkers of Neuroinflammation, Synaptic Dysfunction, and Neurodegeneration..
97:e329-e340.
2021
-
Temporal Correlation of CSF and Neuroimaging in the Amyloid-Tau-Neurodegeneration Model of Alzheimer Disease..
97:e76-e87.
2021
-
Visit-to-Visit Blood Pressure Variability, Neuropathology, and Cognitive Decline..
96:e2812-e2823.
2021
-
Prospective Quantification of CSF Biomarkers in Antibody-Mediated Encephalitis..
96:e2546-e2557.
2021
-
APOE.
96:e2414-e2428.
2021
-
Association of Refractory Pain in the Acute Phase After Subarachnoid Hemorrhage With Continued Outpatient Opioid Use..
96:e2355-e2362.
2021
-
Cardiovascular Risk Factors Across the Life Course and Cognitive Decline: A Pooled Cohort Study..
96:e2212-e2219.
2021
-
APOE.
96:e2272-e2283.
2021
-
National Institute of Neurological Disorders and Stroke Consensus Diagnostic Criteria for Traumatic Encephalopathy Syndrome..
96:848-863.
2021
-
Traumatic Brain Injury and Incidence Risk of Sleep Disorders in Nearly 200,000 US Veterans..
96:e1792-e1799.
2021
-
Association of Digital Clock Drawing With PET Amyloid and Tau Pathology in Normal Older Adults..
96:e1844-e1854.
2021
-
Amyloid PET Imaging in Self-Identified Non-Hispanic Black Participants of the Anti-Amyloid in Asymptomatic Alzheimer's Disease (A4) Study..
96:e1491-e1500.
2021
-
Child Neurology: Intractable Epilepsy and Transient Deficits in a Patient With a History of Herpes Simplex Virus Encephalitis..
96:679-681.
2021
-
Memory Resilience in Alzheimer Disease With Primary Progressive Aphasia..
96:e916-e925.
2021
-
Association of CSF Biomarkers With Hippocampal-Dependent Memory in Preclinical Alzheimer Disease..
96:e1470-e1481.
2021
-
Association of Neighborhood Context, Cognitive Decline, and Cortical Change in an Unimpaired Cohort..
96:e2500-e2512.
2021
-
APOE4.
96:e650-e661.
2020
-
Defining the Lowest Threshold for Amyloid-PET to Predict Future Cognitive Decline and Amyloid Accumulation..
96:e619-e631.
2020
-
Comparison of Clinical Outcomes 1 and 5 Years Post-Injury Following Combat Concussion..
96:e387-e398.
2020
-
Association of Angiotensin II-Stimulating Antihypertensive Use and Dementia Risk: Post Hoc Analysis of the PreDIVA Trial..
96:e67-e80.
2020
-
Apathy and risk of probable incident dementia among community-dwelling older adults..
95:e3280-e3287.
2020
-
Effect of escitalopram dose and treatment duration on CSF Aβ levels in healthy older adults: A controlled clinical trial..
95:e2658-e2665.
2020
-
Effect of escitalopram on Aβ levels and plaque load in an Alzheimer mouse model..
95:e2666-e2674.
2020
-
The impact of delirium on withdrawal of life-sustaining treatment after intracerebral hemorrhage..
95:e2727-e2735.
2020
-
Sex, race, and risk of dementia diagnosis after traumatic brain injury among older veterans..
95:e1768-e1775.
2020
-
Association of genetic risk for Alzheimer disease and hearing impairment..
95:e2225-e2234.
2020
-
Decline in kidney function over the course of adulthood and cognitive function in midlife..
95:e2389-e2397.
2020
-
Sequence of Alzheimer disease biomarker changes in cognitively normal adults: A cross-sectional study..
95:e3104-e3116.
2020
-
Apolipoprotein E.
95:e2086-e2094.
2020
-
Clinician-judged hearing impairment and associations with neuropathologic burden..
95:e1640-e1649.
2020
-
Familial language network vulnerability in primary progressive aphasia..
95:e847-e855.
2020
-
Systolic blood pressure postural changes variability is associated with greater dementia risk..
95:e1932-e1940.
2020
-
Cardiovascular risk factors and accelerated cognitive decline in midlife: The CARDIA Study..
95:e839-e846.
2020
-
Associative memory and in vivo brain pathology in asymptomatic presenilin-1 E280A carriers..
95:e1312-e1321.
2020
-
Blood biomarkers of traumatic brain injury and cognitive impairment in older veterans..
95:e1126-e1133.
2020
-
The presubiculum links incipient amyloid and tau pathology to memory function in older persons..
94:e1916-e1928.
2020
-
Randomized placebo-controlled trial of the effects of aspirin on dementia and cognitive decline..
95:e320-e331.
2020
-
Anatomical evidence of an indirect pathway for word repetition..
94:e594-e606.
2020
-
Differential neurocognitive network perturbation in amnestic and aphasic Alzheimer disease..
94:e699-e704.
2020
-
Diet pattern and prodromal features of Parkinson disease..
95:e2095-e2108.
2020
-
Disease modification and biomarker development in Parkinson disease: Revision or reconstruction?.
94:481-494.
2020
-
GBA.
95:e685-e696.
2020
-
LRRK2.
95:e3428-e3437.
2020
-
Telemedicine in neurology: Telemedicine Work Group of the American Academy of Neurology update..
94:30-38.
2019
-
APOE.
94:e607-e612.
2019
-
Relation between 20-year income volatility and brain health in midlife: The CARDIA study..
93:e1890-e1899.
2019
-
Navigating monoclonal antibody use in breastfeeding women: Do no harm or do little good?.
93:668-672.
2019
-
Clinical EEG slowing correlates with delirium severity and predicts poor clinical outcomes..
93:e1260-e1271.
2019
-
High-precision plasma β-amyloid 42/40 predicts current and future brain amyloidosis..
93:e1647-e1659.
2019
-
Midlife adiposity predicts cognitive decline in the prospective Multicenter AIDS Cohort Study..
93:e261-e271.
2019
-
Cross-sectional associations of tau-PET signal with cognition in cognitively unimpaired adults..
93:e29-e39.
2019
-
Framing advance care planning in Parkinson disease: Patient and care partner perspectives..
92:e2571-e2579.
2019
-
Dietary patterns during adulthood and cognitive performance in midlife: The CARDIA study..
92:e1589-e1599.
2019
-
The prognostic value of ATN Alzheimer biomarker profiles in cognitively normal individuals..
92:643-644.
2019
-
Perivascular spaces contribute to cognition beyond other small vessel disease markers..
92:e1309-e1321.
2019
-
Vitamin D levels and risk of delirium: A mendelian randomization study in the UK Biobank..
92:e1387-e1394.
2019
-
Genetic and lifestyle risk factors for MRI-defined brain infarcts in a population-based setting..
92:e486-503.
2019
-
Physical activity and prodromal features of Parkinson disease..
93:e2157-e2169.
2019
-
Prediagnostic plasma metabolomics and the risk of amyotrophic lateral sclerosis..
92:e2089-e2100.
2019
-
Revisiting protein aggregation as pathogenic in sporadic Parkinson and Alzheimer diseases..
92:329-337.
2019
-
Sex differences by design and outcome in the Safety of Urate Elevation in PD (SURE-PD) trial..
93:e1328-e1338.
2019
-
Word comprehension in temporal cortex and Wernicke area: A PPA perspective..
92:e224-e233.
2018
-
Military-related risk factors in female veterans and risk of dementia..
92:e205-e211.
2018
-
CNS disease-related protein variants as blood-based biomarkers in traumatic brain injury..
91:702-709.
2018
-
Longitudinal cognitive and biomarker changes in dominantly inherited Alzheimer disease..
91:e1295-e1306.
2018
-
APOE.
91:e1182-e1195.
2018
-
Utilizing semantic intrusions to identify amyloid positivity in mild cognitive impairment..
91:e976-e984.
2018
-
Influence of tau PET, amyloid PET, and hippocampal volume on cognition in Alzheimer disease..
91:e859-e866.
2018
-
Serum glutamine and hospital-acquired infections after aneurysmal subarachnoid hemorrhage..
91:e421-e426.
2018
-
Baseline NAWM structural integrity and CBF predict periventricular WMH expansion over time..
90:e2119-e2126.
2018
-
Mild TBI and risk of Parkinson disease: A Chronic Effects of Neurotrauma Consortium Study..
90:e1771-e1779.
2018
-
APOE.
90:e1605-e1612.
2018
-
Brain structure and cognition 3 years after the end of an early menopausal hormone therapy trial..
90:e1404-e1412.
2018
-
Age-accelerated cognitive decline in asymptomatic adults with CSF β-amyloid..
90:e1306-e1315.
2018
-
Biomarker pattern of ARIA-E participants in phase 3 randomized clinical trials with bapineuzumab..
90:e877-e886.
2018
-
Neurogranin as a predictor of memory and executive function decline in MCI patients..
90:e887-e895.
2018
-
Dementia and motor vehicle crash hospitalizations: Role of physician reporting laws..
90:e808-e813.
2018
-
Integration of risk factors for Parkinson disease in 2 large longitudinal cohorts..
90:e1646-e1653.
2018
-
Neurology residency training in 2017: A survey of preparation, perspectives, and plans..
92:76-83.
2018
-
Prediagnostic plasma branched-chain amino acids and the risk of amyotrophic lateral sclerosis..
92:e2081-e2088.
2018
-
Multiple pathways of reserve simultaneously present in cognitively normal older adults..
90:e197-e205.
2017
-
Vascular and dopaminergic contributors to mild parkinsonian signs in older adults..
90:e223-e229.
2017
-
Alzheimer's Disease-Related Dementias Summit 2016: National research priorities..
89:2381-2391.
2017
-
Lower cardiac index levels relate to lower cerebral blood flow in older adults..
89:2327-2334.
2017
-
COL4A2.
89:1829-1839.
2017
-
Metformin vs sulfonylurea use and risk of dementia in US veterans aged ≥65 years with diabetes..
89:1877-1885.
2017
-
Neurogranin, a synaptic protein, is associated with memory independent of Alzheimer biomarkers..
89:1782-1788.
2017
-
Sex differences in the prevalence of genetic mutations in FTD and ALS: A meta-analysis..
89:1633-1642.
2017
-
Subjective memory complaints in preclinical autosomal dominant Alzheimer disease..
89:1464-1470.
2017
-
Longitudinal diffusion changes following postoperative delirium in older people without dementia..
89:1020-1027.
2017
-
Developing an outline for teleneurology curriculum: AAN Telemedicine Work Group recommendations..
89:951-959.
2017
-
Magnesium, hemostasis, and outcomes in patients with intracerebral hemorrhage..
89:813-819.
2017
-
Slowing gait and risk for cognitive impairment: The hippocampus as a shared neural substrate..
89:336-342.
2017
-
Functional network integrity presages cognitive decline in preclinical Alzheimer disease..
89:29-37.
2017
-
BDNF.
88:2098-2106.
2017
-
Effect of a long-term intensive lifestyle intervention on prevalence of cognitive impairment..
88:2026-2035.
2017
-
A phase 3 trial of IV immunoglobulin for Alzheimer disease..
88:1768-1775.
2017
-
Hippocampal hypometabolism in older adults with memory complaints and increased amyloid burden..
88:1759-1767.
2017
-
Cued memory decline in biomarker-defined preclinical Alzheimer disease..
88:1431-1438.
2017
-
Physical activity and hippocampal volume in middle-aged patients with type 1 diabetes..
88:1564-1570.
2017
-
Multimodal characterization of older APOE2 carriers reveals selective reduction of amyloid load..
88:569-576.
2017
-
Intake of dairy foods and risk of Parkinson disease..
89:46-52.
2017
-
Olfaction and risk of dementia in a biracial cohort of older adults..
88:456-462.
2016
-
The link between sleep-disordered breathing and cognition in the elderly: New opportunities?.
88:424-425.
2016
-
Dementia risk in renal dysfunction: A systematic review and meta-analysis of prospective studies..
88:198-208.
2016
-
Asymptomatic Alzheimer disease: Defining resilience..
87:2443-2450.
2016
-
Hippocampal volumes predict risk of dementia with Lewy bodies in mild cognitive impairment..
87:2317-2323.
2016
-
Slow gait, white matter characteristics, and prior 10-year interleukin-6 levels in older adults..
87:1993-1999.
2016
-
Aphasic variant of Alzheimer disease: Clinical, anatomic, and genetic features..
87:1337-43.
2016
-
Effects of hormone therapy on brain structure: A randomized controlled trial..
87:887-96.
2016
-
Temporal T807 binding correlates with CSF tau and phospho-tau in normal elderly..
87:920-6.
2016
-
Neuroimaging overuse is more common in Medicare compared with the VA..
87:792-8.
2016
-
Polygenic risk of Alzheimer disease is associated with early- and late-life processes..
87:481-8.
2016
-
A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers..
87:539-47.
2016
-
Accelerating rates of cognitive decline and imaging markers associated with β-amyloid pathology..
86:1887-96.
2016
-
Frontotemporal networks and behavioral symptoms in primary progressive aphasia..
86:1393-1399.
2016
-
Hostile attitudes and effortful coping in young adulthood predict cognition 25 years later..
86:1227-34.
2016
-
Chronic kidney disease, cerebral blood flow, and white matter volume in hypertensive adults..
86:1208-16.
2016
-
Prospective study of plasma urate and risk of Parkinson disease in men and women..
86:520-6.
2016
-
Memory complaints and risk of cognitive impairment after nearly 2 decades among older women..
85:1852-8.
2015
-
Mediterranean diet and brain structure in a multiethnic elderly cohort..
85:1744-51.
2015
-
Evaluation of outcome measures for neurogenic claudication: A patient-centered approach..
85:1250-6.
2015
-
Cerebral amyloidosis associated with cognitive decline in autosomal dominant Alzheimer disease..
85:790-8.
2015
-
Amyloid-β 11C-PiB-PET imaging results from 2 randomized bapineuzumab phase 3 AD trials..
85:692-700.
2015
-
Postmenopausal hormone therapy, type 2 diabetes mellitus, and brain volumes..
85:1131-8.
2015
-
Cognitive correlates of white matter lesion load and brain atrophy: the Northern Manhattan Study..
85:441-9.
2015
-
Cognitive activity relates to cognitive performance but not to Alzheimer disease biomarkers..
85:48-55.
2015
-
Subjective cognitive concerns, amyloid-β, and neurodegeneration in clinically normal elderly..
85:56-62.
2015
-
Longitudinal patient-oriented outcomes in neuropathy: Importance of early detection and falls..
85:71-9.
2015
-
Subclinical cerebrovascular disease inversely associates with learning ability: The NOMAS..
84:2362-7.
2015
-
Tetrahydrocannabinol for neuropsychiatric symptoms in dementia: A randomized controlled trial..
84:2338-46.
2015
-
Odor identification and Alzheimer disease biomarkers in clinically normal elderly..
84:2153-60.
2015
-
Association of hospitalization with long-term cognitive and brain MRI changes in the ARIC cohort..
84:1443-53.
2015
-
"Noncognitive" symptoms of early Alzheimer disease: a longitudinal analysis..
84:617-22.
2015
-
PARK10 is a major locus for sporadic neuropathologically confirmed Parkinson disease..
84:972-80.
2015
-
Brain amyloidosis ascertainment from cognitive, imaging, and peripheral blood protein measures..
84:729-37.
2015
-
Development and validation of risk index for cognitive decline using blood-derived markers..
84:696-702.
2015
-
Inflammation, negative nitrogen balance, and outcome after aneurysmal subarachnoid hemorrhage..
84:680-7.
2015
-
Olfactory deficits predict cognitive decline and Alzheimer dementia in an urban community..
84:182-9.
2014
-
Factors associated with cognitive evaluations in the United States..
84:64-71.
2014
-
Physical activity attenuates age-related biomarker alterations in preclinical AD..
83:1753-60.
2014
-
Cervical spine fracture associated with ankylosing spondylitis..
83:-.
2014
-
Asymmetry of cortical decline in subtypes of primary progressive aphasia..
83:1184-91.
2014
-
Vitamin D and the risk of dementia and Alzheimer disease..
83:920-8.
2014
-
Traumatic brain injury and risk of dementia in older veterans..
83:312-9.
2014
-
Symptom onset in autosomal dominant Alzheimer disease: a systematic review and meta-analysis..
83:253-60.
2014
-
Amyloid and APOE ε4 interact to influence short-term decline in preclinical Alzheimer disease..
82:1760-7.
2014
-
Cardiorespiratory fitness and cognitive function in middle age: the CARDIA study..
82:1339-46.
2014
-
Contribution of Alzheimer disease to mortality in the United States..
82:1045-50.
2014
-
Long-term survival after ischemic stroke in patients with atrial fibrillation..
82:1033-7.
2014
-
Acute infection contributes to racial disparities in stroke mortality..
82:914-21.
2014
-
Higher RBC EPA + DHA corresponds with larger total brain and hippocampal volumes: WHIMS-MRI study..
82:435-42.
2014
-
Rates of β-amyloid accumulation are independent of hippocampal neurodegeneration..
82:1605-12.
2014
-
Supply and demand analysis of the current and future US neurology workforce..
82:2254-5.
2014
-
Long-term predictive value of the Framingham Risk Score for Stroke in HIV-positive vs HIV-negative men..
81:2094-102.
2013
-
ω-3 fatty acids and domain-specific cognitive aging: secondary analyses of data from WHISCA..
81:1484-91.
2013
-
The pattern of atrophy in familial Alzheimer disease: volumetric MRI results from the DIAN study..
81:1425-33.
2013
-
Naming vs knowing faces in primary progressive aphasia: a tale of 2 hemispheres..
81:658-64.
2013
-
Neuropathologic basis of white matter hyperintensity accumulation with advanced age..
81:977-83.
2013
-
Cocoa, neurovascular coupling, and neurodegeneration: the good, the bad, and the ugly..
81:863-4.
2013
-
Imaging markers for Alzheimer disease: which vs how..
81:487-500.
2013
-
Impaired default network functional connectivity in autosomal dominant Alzheimer disease..
81:736-44.
2013
-
Clinical Reasoning: a 44-year-old woman with headache followed by sudden neurologic decline..
80:e136-41.
2013
-
Cognitive reserve associated with FDG-PET in preclinical Alzheimer disease..
80:1194-201.
2013
-
Amyloid imaging and CSF biomarkers in predicting cognitive impairment up to 7.5 years later..
80:1784-91.
2013
-
CSF biomarkers of Alzheimer disease: "noncognitive" outcomes..
81:2028-31.
2013
-
Unrecognized vitamin D3 deficiency is common in Parkinson disease: Harvard Biomarker Study..
81:1531-7.
2013
-
Visualization of nigrosome 1 and its loss in PD: pathoanatomical correlation and in vivo 7 T MRI..
81:534-40.
2013
-
Teaching Video NeuroImages: phenytoin-induced orofacial dyskinesias..
79:-.
2012
-
Stroke symptoms signal worse outcomes in patients with end-stage renal disease..
79:960-1.
2012
-
Trajectory of white matter hyperintensity burden preceding mild cognitive impairment..
79:741-7.
2012
-
Amyloid-β assessed by florbetapir F 18 PET and 18-month cognitive decline: a multicenter study..
79:1636-44.
2012
-
Novel late-onset Alzheimer disease loci variants associate with brain gene expression..
79:221-8.
2012
-
Genotype patterns at PICALM, CR1, BIN1, CLU, and APOE genes are associated with episodic memory..
78:1464-71.
2012
-
Pearls & Oysters: the effects of renal replacement therapy on cerebral autoregulation..
78:e36-8.
2012
-
Memory after silent stroke: hippocampus and infarcts both matter..
78:38-46.
2012
-
CSF VILIP-1 predicts rates of cognitive decline in early Alzheimer disease..
78:709-19.
2012
-
Caffeine in Parkinson disease: better for cruise control than snooze patrol?.
79:616-8.
2012
-
Habitual intake of dietary flavonoids and risk of Parkinson disease..
78:1138-45.
2012
-
Indicators of amyloid burden in a population-based study of cognitively normal elderly..
79:1570-7.
2012
-
Plasma multianalyte profiling in mild cognitive impairment and Alzheimer disease..
79:897-905.
2012
-
Nutrient biomarker patterns, cognitive function, and MRI measures of brain aging..
78:241-9.
2011
-
Effect of rebleeding on the course and incidence of vasospasm after subarachnoid hemorrhage..
78:31-7.
2011
-
Amyloid vs FDG-PET in the differential diagnosis of AD and FTLD..
77:2034-42.
2011
-
A phase 2 randomized trial of ELND005, scyllo-inositol, in mild to moderate Alzheimer disease..
77:1253-62.
2011
-
Advanced glycation end product level, diabetes, and accelerated cognitive aging..
77:1351-6.
2011
-
Plasma Aβ and PET PiB binding are inversely related in mild cognitive impairment..
77:125-31.
2011
-
Progression of language decline and cortical atrophy in subtypes of primary progressive aphasia..
76:1804-10.
2011
-
Distinct clinical and metabolic deficits in PCA and AD are not related to amyloid distribution..
76:1789-96.
2011
-
Alzheimer-signature MRI biomarker predicts AD dementia in cognitively normal adults..
76:1395-402.
2011
-
Defaulting on the default network: increased risk for dementia..
76:498-500.
2011
-
Improving CSF biomarker accuracy in predicting prevalent and incident Alzheimer disease..
76:501-10.
2011
-
Use of ibuprofen and risk of Parkinson disease..
76:863-9.
2011
-
HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study..
75:2087-96.
2010
-
Albuminuria and the risk of incident stroke and stroke types in older adults..
75:1343-50.
2010
-
Use of anticholinergics and the risk of cognitive impairment in an African American population..
75:152-9.
2010
-
Longitudinal fMRI in elderly reveals loss of hippocampal activation with clinical decline..
74:1969-76.
2010
-
Cognitively unimpaired HIV-positive subjects do not have increased 11C-PiB: a case-control study..
75:111-5.
2010
-
The delayed-start study in Parkinson disease: can't satisfy everyone: Rasagiline, Parkinson neuroprotection, and delayed-start trials: still no satisfaction?.
75:1943-4; author reply 1944-5.
2010
-
A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease..
73:2061-70.
2009
-
ALS motor phenotype heterogeneity, focality, and spread: deconstructing motor neuron degeneration..
73:805-11.
2009
-
Conflict monitoring in early frontotemporal dementia..
73:349-55.
2009
-
Cognitive impairment risk: white matter hyperintensity progression matters..
73:120-5.
2009
-
Surrogate consent for dementia research: a national survey of older Americans..
72:149-55.
2009
-
CSF biomarkers of Alzheimer disease in HIV-associated neurologic disease..
73:1982-7.
2009
-
Delirium accelerates cognitive decline in Alzheimer disease..
72:1570-5.
2009
-
Family history of melanoma and Parkinson disease risk..
73:1286-91.
2009
-
Obesity and restless legs syndrome in men and women..
72:1255-61.
2009
-
Survival in Alzheimer disease: a multiethnic, population-based study of incident cases..
71:1489-95.
2008
-
A novel PRNP-P105S mutation associated with atypical prion disease and a rare PrPSc conformation..
71:1431-8.
2008
-
Fatigue in levodopa-naive subjects with Parkinson disease..
71:481-5.
2008
-
Use of statins and incidence of dementia and cognitive impairment without dementia in a cohort study..
71:344-50.
2008
-
APOE epsilon 4 allele predicts faster cognitive decline in mild Alzheimer disease..
70:1842-9.
2008
-
A longitudinal study of drivers with Alzheimer disease..
70:1171-8.
2008
-
No advantage of A beta 42-lowering NSAIDs for prevention of Alzheimer dementia in six pooled cohort studies..
70:2291-8.
2008
-
Trajectories of brain loss in aging and the development of cognitive impairment..
70:828-33.
2007
-
Vascular factors predict rate of progression in Alzheimer disease..
69:1850-8.
2007
-
Relationship of fMRI activation to clinical trial memory measures in Alzheimer disease..
69:1331-41.
2007
-
Mediterranean diet and Alzheimer disease mortality..
69:1084-93.
2007
-
Does statin use decrease the amount of Alzheimer disease pathology in the brain?.
69:E8-11.
2007
-
Brain volumes in Guam dementia vs Parkinson dementia complex vs aging Chamorro adults..
69:196-9.
2007
-
Impairment of nonverbal recognition in Alzheimer disease: a PET O-15 study..
69:32-41.
2007
-
Inflammatory markers and the risk of Alzheimer disease: the Framingham Study..
68:1902-8.
2007
-
Cycad exposure and risk of dementia, MCI, and PDC in the Chamorro population of Guam..
68:1764-71.
2007
-
Prevalence of dementia in Chamorros on Guam: relationship to age, gender, education, and APOE..
68:1772-81.
2007
-
AMPA potentiator treatment of cognitive deficits in Alzheimer disease..
68:1008-12.
2007
-
Hippocampal and entorhinal atrophy in mild cognitive impairment: prediction of Alzheimer disease..
68:828-36.
2007
-
Fluctuations of CSF amyloid-beta levels: implications for a diagnostic and therapeutic biomarker..
68:666-9.
2007
-
Hypertension, hypercholesterolemia, diabetes, and risk of Parkinson disease..
69:1688-95.
2007
-
Temporal relationship between cigarette smoking and risk of Parkinson disease..
68:764-8.
2007
-
Multiple system atrophy presenting with language impairment..
67:726-7.
2006
-
Longitudinal study of effects of patient characteristics on direct costs in Alzheimer disease..
67:998-1005.
2006
-
Pilot clinical trial of gabapentin to decrease postoperative delirium in older patients..
67:1251-3.
2006
-
Projected costs of ischemic stroke in the United States..
67:1390-5.
2006
-
Rapid infusion of cold saline (4 degrees C) as adjunctive treatment of fever in patients with brain injury..
66:1739-41.
2006
-
Clinical features associated with costs in early AD: baseline data from the Predictors Study..
66:1021-8.
2006
-
Brain volume loss in MCI predicts dementia..
66:233-5.
2006
-
Inclusion-body myositis and Alzheimer disease: two sides of the same coin, or different currencies altogether?.
66:S65-8.
2006
-
Effects of a gamma-secretase inhibitor in a randomized study of patients with Alzheimer disease..
66:602-4.
2006
-
fMRI evidence of compensatory mechanisms in older adults at genetic risk for Alzheimer disease..
65:1514-5; author reply 1514-5.
2005
-
Increased hippocampal activation in mild cognitive impairment compared to normal aging and AD..
65:404-11.
2005
-
Ethnic differences in acetylcholinesterase inhibitor use for Alzheimer disease..
65:159-62.
2005
-
Cognitive function predicts first-time stroke and heart disease..
64:1750-5.
2005
-
Motor signs predict poor outcomes in Alzheimer disease..
64:1696-703.
2005
-
Neuropsychological predictors of dependency in patients with Alzheimer disease..
64:1027-31.
2005
-
Immunization therapy for Alzheimer disease?.
64:10-2.
2005
-
Physical activity and the risk of Parkinson disease..
64:664-9.
2005
-
Evaluation of HIV RNA and markers of immune activation as predictors of HIV-associated dementia..
63:2084-90.
2004
-
Impact of antioxidants, zinc, and copper on cognition in the elderly: a randomized, controlled trial..
63:1705-7.
2004
-
Motor signs during the course of Alzheimer disease..
63:975-82.
2004
-
APOE-dependent PET patterns of brain activation in Alzheimer disease..
63:913-5.
2004
-
Beta-synuclein gene alterations in dementia with Lewy bodies..
63:805-11.
2004
-
Psychiatric comorbidities in patients with Parkinson disease and psychosis..
63:293-300.
2004
-
Clinical profile and course of cognitively normal patients evaluated in memory disorders clinics..
62:1639-42.
2004
-
Genetic influences on memory performance in familial Alzheimer disease..
62:414-21.
2004
-
Plasma A[beta]40 and A[beta]42 and Alzheimer's disease: relation to age, mortality, and risk..
61:1185-90.
2003
-
Wrinkles and folds of the prion protein..
61:1168-9.
2003
-
Changes in premorbid brain volume predict Alzheimer's disease pathology..
61:487-92.
2003
-
Semantic memory deficit with a left thalamic infarct..
61:252-4.
2003
-
Cognition following bilateral implants of embryonic dopamine neurons in PD: a double blind study..
60:1938-43.
2003
-
Inter-rater reliability of a clinical staging of HIV-associated cognitive impairment..
60:1467-73.
2003
-
Natural history of cognitive decline in the old old..
60:1489-94.
2003
-
Neuroprotective agents for clinical trials in Parkinson's disease: a systematic assessment..
60:1234-40.
2003
-
Predictors of nursing home placement in Huntington disease..
60:998-1001.
2003
-
Spinal meningioma causing diffuse leptomeningeal enhancement..
60:350-1.
2003
-
Adenosine A2A receptors in neuroadaptation to repeated dopaminergic stimulation: implications for the treatment of dyskinesias in Parkinson's disease..
61:S74-81.
2003
-
Caffeine, postmenopausal estrogen, and risk of Parkinson's disease..
60:790-5.
2003
-
Monoamine oxidase B inhibition and neuroprotection: studies on selective adenosine A2A receptor antagonists..
61:S62-8.
2003
-
Neuroprotection by caffeine and more specific A2A receptor antagonists in animal models of Parkinson's disease..
61:S55-61.
2003
-
Sleep regulation in adenosine A2A receptor-deficient mice..
61:S94-6.
2003
-
The association of incident dementia with mortality in PD..
59:1708-13.
2002
-
Premorbid weight, body mass, and varsity athletics in ALS..
59:773-5.
2002
-
"Out, damned spot! out, I say!...": issues related to prion decontamination..
59:488-9.
2002
-
Mortality in patients with dementia after ischemic stroke..
59:537-43.
2002
-
Primary care expenditures before the onset of Alzheimer's disease..
59:573-8.
2002
-
A national study of the quantity and cost of informal caregiving for the elderly with stroke..
58:1754-9.
2002
-
Phases of A beta-deposition in the human brain and its relevance for the development of AD..
58:1791-800.
2002
-
Association between the APOE genotype and psychopathologic symptoms in Alzheimer's disease..
58:1182-8.
2002
-
The relationship of hypertension in the elderly to AD, vascular dementia, and cognitive function..
58:1175-81.
2002
-
Functional deficits in patients with mild cognitive impairment: prediction of AD..
58:758-64.
2002
-
Reduced intraepidermal nerve fiber density in HIV-associated sensory neuropathy..
58:115-9.
2002
-
Caffeinated clues and the promise of adenosine A(2A) antagonists in PD..
58:1154-60.
2002
-
Influence of leisure activity on the incidence of Alzheimer's disease..
57:2236-42.
2001
-
Inherited prion disease caused by the V210I mutation: transmission to transgenic mice..
57:2198-205.
2001
-
Clinical trials in HIV-associated cognitive impairment: cognitive and functional outcomes..
56:415-8.
2001
-
Incidence of AD in African-Americans, Caribbean Hispanics, and Caucasians in northern Manhattan..
56:49-56.
2001
-
Presenilin-1-associated abnormalities in regional cerebral perfusion..
56:1545-51.
2001
-
Different brain networks mediate task performance in normal aging and AD: defining compensation..
55:1291-7.
2000
-
Late-onset SCA2: 33 CAG repeats are sufficient to cause disease..
55:569-72.
2000
-
Motor impairment in PD: relationship to incident dementia and age..
55:539-44.
2000
-
Poor verbal working memory across intellectual level in boys with Duchenne dystrophy..
54:2127-32.
2000
-
Frequency and clinical determinants of dementia after ischemic stroke..
54:1124-31.
2000
-
Rate of memory decline in AD is related to education and occupation: cognitive reserve?.
53:1942-7.
1999
-
Influence of APOE genotype on familial aggregation of AD in an urban population..
53:789-94.
1999
-
Assessment of cognition in advanced AD: the test for severe impairment..
52:1689-91.
1999
-
Selective decline in memory function among healthy elderly..
52:1392-6.
1999
-
The influence of smoking on the risk of Alzheimer's disease..
52:1408-12.
1999
-
Risk of Alzheimer's disease in relatives of Parkinson's disease patients with and without dementia..
52:719-24.
1999
-
Increased risk of mortality in AD patients with higher education?.
51:-.
1998
-
Creutzfeldt-Jakob disease (CJD) after blood product transfusion from a donor with CJD..
50:1872-3.
1998
-
Cognitive test performance among nondemented elderly African Americans and whites..
50:1238-45.
1998
-
Postmenopausal estrogen use and Parkinson's disease with and without dementia..
50:1141-3.
1998
-
Cognitive function in nondemented older women who took estrogen after menopause..
50:368-73.
1998
-
Changes of hippocampal N-acetyl aspartate and volume in Alzheimer's disease. A proton MR spectroscopic imaging and MRI study..
49:1513-21.
1997
-
An association between head circumference and Alzheimer's disease in a population-based study of aging and dementia..
49:30-7.
1997
-
Participation in clinical trials and long-term outcomes in Alzheimer's disease..
49:38-43.
1997
-
Dementia after stroke increases the risk of long-term stroke recurrence..
48:1317-25.
1997
-
Mutation of the prion protein gene at codon 208 in familial Creutzfeldt-Jakob disease..
47:1305-12.
1996
-
A preliminary study of apolipoprotein E genotype and psychiatric manifestations of Alzheimer's disease..
47:256-9.
1996
-
Neurologic consequences of HTLV-II infection in injection-drug users..
46:1556-60.
1996
-
The Clinical Dementia Rating scale: community-based validation of "profound' and "terminal' stages..
46:1746-9.
1996
-
Noninvasive perfusion MRI in Alzheimer's disease: a preliminary report..
47:1339-42.
1996
-
Prion disease (PrP-A117V) presenting with ataxia instead of dementia..
45:2042-50.
1995
-
Consistency of clinical diagnosis in a community-based longitudinal study of dementia and Alzheimer's disease..
45:2159-64.
1995
-
Neuropsychological changes in a prospectively followed cohort of homosexual and bisexual men with and without HIV infection..
45:467-72.
1995
-
Neuropsychological characteristics of preclinical dementia in Parkinson's disease..
45:1691-6.
1995
-
Neuropsychological detection and characterization of preclinical Alzheimer's disease..
45:957-62.
1995
-
Neuropsychological test performance in African-American and white patients with Alzheimer's disease..
45:2207-11.
1995
-
Plasmapheresis in fulminant acute disseminated encephalomyelitis..
45:824-7.
1995
-
Subtle extrapyramidal signs and incident dementia: a follow-up analysis..
45:-.
1995
-
Kennedy's disease..
43:2424-5.
1993
-
Word comprehension in temporal cortex and Wernicke area: A PPA perspective
2019
-
Rapid Revascularization of Simultaneous Bilateral ICA Occlusions causing Coma
2018
-
Word comprehension in temporal cortex and Wernicke area
2018
-
Rapid Revascularization of Simultaneous Bilateral ICA Occlusions causing Coma
2018
Identity
International Standard Serial Number (ISSN)
-
0028-3878
-
1526-632X
-
1526632X 00283878